Skip to content

Colistimethate

Coly-mycin M, Colobreathe (colistimethate) is an unknown pharmaceutical. Colistimethate was first approved as Coly-mycin M on 1982-01-01. It is used to treat bacterial infections, escherichia coli infections, klebsiella infections, pseudomonas infections, and urinary tract infections in the USA. It has been approved in Europe to treat cystic fibrosis.
Trade Name Colobreathe
Common Name Colistimethate
Indication bacterial infections, cystic fibrosis, escherichia coli infections, klebsiella infections, pseudomonas infections, urinary tract infections
Drug Class
Colistimethate
Get full access now